Alyeska Investment Group, L.P. Acer Therapeutics Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$17.71 - $21.6 $237,119 - $289,202	-13,389 Reduced 14.98%	76,009 $1.64 Million
Q1 2018 May 15, 2018	BUY	$14.81 - $20.22 $213,234 - $291,127	14,398 Added 19.2%	89,398 $1.72 Million
Q4 2017 Feb 14, 2018	BUY	$11.81 - $19.35 $885,750 - $1.45 Million	75,000	75,000 $1.04 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.